Van Damme P - Search Results

1

Horizontal transmission of hepatitis B virus.

Van Damme P, Cramm M, Van der Auwera JC, Vranckx R, Meheus A. Van Damme P, et al. Among authors: van der auwera jc. Lancet. 1995 Jan 7;345(8941):27-9. doi: 10.1016/s0140-6736(95)91155-3. Lancet. 1995. PMID: 7799703

2

Cost-effectiveness analysis of hepatitis A prevention in travellers.

Tormans G, Van Damme P, Van Doorslaer E. Tormans G, et al. Among authors: van doorslaer e, van damme p. Vaccine. 1992;10 Suppl 1:S88-92. doi: 10.1016/0264-410x(92)90554-w. Vaccine. 1992. PMID: 1335668

3

Hepatitis A vaccination.

Van Damme P, Tormans G, Van Doorslaer E. Van Damme P, et al. Among authors: van doorslaer e. Lancet. 1992 Sep 5;340(8819):617. doi: 10.1016/0140-6736(92)92157-b. Lancet. 1992. PMID: 1355198 No abstract available.

4

Heat stability of a recombinant DNA hepatitis B vaccine.

Van Damme P, Cramm M, Safary A, Vandepapelière P, Meheus A. Van Damme P, et al. Vaccine. 1992;10(6):366-7. doi: 10.1016/0264-410x(92)90064-q. Vaccine. 1992. PMID: 1534639 Clinical Trial.

5

Hepatitis C in institutionalized children.

Vranckx R, Van Damme P. Vranckx R, et al. Among authors: van damme p. N Engl J Med. 1990 Jul 5;323(1):64. doi: 10.1056/NEJM199007053230115. N Engl J Med. 1990. PMID: 2113186 No abstract available.

6

Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.

Van Damme P, Vranckx R, Meheus A. Van Damme P, et al. Vaccine. 1990 Mar;8 Suppl:S53-5; discussion S60-2. doi: 10.1016/0264-410x(90)90236-f. Vaccine. 1990. PMID: 2139285 Clinical Trial.

7

Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients.

Van Damme P, Vranckx R, Safary A, André FE, Meheus A. Van Damme P, et al. Am J Med. 1989 Sep 4;87(3A):26S-29S. doi: 10.1016/0002-9343(89)90527-5. Am J Med. 1989. PMID: 2528294

8

Hepatitis B prevention in Europe: a preliminary economic evaluation.

Van Damme P, Tormans G, Beutels P, Van Doorslaer E. Van Damme P, et al. Among authors: van doorslaer e. Vaccine. 1995;13 Suppl 1:S54-7. doi: 10.1016/0264-410x(95)93549-o. Vaccine. 1995. PMID: 7571833 Free article.

9

Increased risk for hepatitis A among female day nursery workers in Belgium.

Jacques P, Moens G, Van Damme P, Goubau P, Vranckx R, Steeno J, Muylle L, Desmyter J. Jacques P, et al. Among authors: van damme p. Occup Med (Lond). 1994 Dec;44(5):259-61. doi: 10.1093/occmed/44.5.259. Occup Med (Lond). 1994. PMID: 7841420

10

Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity.

Van Damme P, Matheï C, Thoelen S, Meheus A, Safary A, André FE. Van Damme P, et al. J Med Virol. 1994 Dec;44(4):435-41. doi: 10.1002/jmv.1890440422. J Med Virol. 1994. PMID: 7897376 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results